Suits Resume as Invitrogen v. Bio-Rad and Amersham v. PerkinElmer Miss Settlements | GenomeWeb
Two separate patent-infringement cases among four companies in the BCW Index are proceeding after the parties in the cases failed to reach settlements, and stays on the litigation were lifted.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.